Haemonetics Banks on Growing Plasma Arm, Innovation - Hims & Hers Health (NYSE:HIMS), Haemonetics (NYSE:HAE)
Haemonetics (NYSE: HAE) has been gaining from business growth within Plasma, Hospital and Hemostasis Management. Its new launches also aid growth. The stock carries a Zacks Rank #1 (Strong Buy) currently.
United States Haemonetics Corporation While Hims Hers Health Persona Technology Hims Hers Health Haemonetics Corporation Price
Source: benzinga.com